2026年全球腸道晶片市場報告

近年來，腸道晶片（ICU）技術的市場規模迅速擴張。預計該市場規模將從2025年的7.7億美元成長到2026年的8.7億美元，複合年成長率（CAGR）為12.7%。這一成長歸功於微流體技術的進步、人類細胞培養系統研究的增加、對動物實驗替代方案的需求不斷成長、學術界對「器官晶片」原型技術的早期應用以及對生物技術研究基礎設施投資的增加。

預計未來幾年腸道晶片市場將快速成長，到2030年將達到13.8億美元，複合年成長率（CAGR）為12.3%。預測期內的成長主要歸功於個人化醫療和精準藥物檢測的擴展、製藥業對體外建模系統的日益依賴、微生物組研究和腸道健康研究的進展、多器官整合晶片平台的開發以及監管機構對替代檢測技術的大力支持。預測期內的關鍵趨勢包括：能夠即時分析腸道生理的微流體腸道模擬平台；用於個性化藥物反應測試的「器官晶片」整合；利用先進的腸道晶片系統模擬微生物組相互作用；利用微工程腸道模型進行高通量毒性篩檢；以及用於疾病建模和再生醫學研究的基於幹細胞的腸道組織複製。

預計未來幾年，胃腸道疾病發病率的上升將推動腸道晶片市場的發展。胃腸道疾病影響消化器官系統，包括胃、腸、結腸和直腸，並常導致慢性發炎、消化功能障礙和嚴重的腸道併發症。這些疾病的盛行率上升主要歸因於不健康的飲食習慣和加工食品攝取量的增加，這些因素會對消化系統健康產生負面影響。腸道晶片技術透過模擬人體腸道的功能和疾病狀態，為胃腸道疾病的研究提供支持，使研究人員能夠闡明疾病機制、評估藥物反應並開發新的治療方法。例如，根據美國癌症協會（一家總部位於美國的非營利癌症組織）的數據，截至2024年1月，大腸直腸癌（CRC）是美國第二大癌症相關死亡原因，預計2024年將有約53,010人死於該疾病。這一數字較前一年的估計死亡人數52,550人增加。因此，胃腸道疾病盛行率的上升正在推動腸道晶片市場的成長。

領先的腸道晶片製造商正致力於開發先進的解決方案，例如低藥物吸收率的剛性微流體晶片，以提高吸收、分佈、代謝、排泄和毒性研究的預測準確性。低藥物吸收率的剛性微流體晶片是一種先進的「器官晶片」裝置，採用特殊塑膠材料製成，可在實驗過程中最大限度地減少化合物損失，同時保持可控的流體流動和生理適宜的細胞環境。例如，總部位於美國的生物技術公司Emulate Inc.於2024年9月推出了用於先進器官晶片應用的「Chip-R1剛性晶片」。該平台採用低藥物吸收的塑膠結構，改進了血管通道設計以微流體生理適宜的剪切應力，並增強了與人體相關組織模型中吸收、分佈、代謝、排泄和毒性測試應用的兼容性。

目錄

第1章執行摘要

第2章 市場特徵

• 市場定義和範圍
• 市場區隔
• 主要產品和服務概述
• 全球腸道晶片市場：吸引力評分及分析
• 成長潛力分析、競爭評估、策略適宜性評估、風險狀況評估

第3章 市場供應鏈分析

• 供應鏈與生態系概述
• 清單：主要原料、資源和供應商
• 主要經銷商和通路合作夥伴名單
• 主要最終用戶列表

第4章：全球市場趨勢與策略

• 關鍵科技與未來趨勢
  • 生物技術、基因組學和精準醫療
  • 人工智慧和自主智慧
  • 物聯網、智慧基礎設施、互聯生態系統
  • 數位化、雲端運算、巨量資料、網路安全
  • 工業4.0和智慧製造
• 主要趨勢
  • 微流體腸道模擬平台，可對腸道生理功能進行即時分析。
  • 用於個人化藥物反應測試的晶片器官整合
  • 利用先進的「腸道晶片」系統對微生物組相互作用進行建模
  • 利用微工程腸道模型進行高通量毒性篩檢。
  • 利用幹細胞重建腸道組織，用於疾病模型建構和再生醫學研究。

第5章 終端用戶產業市場分析

• 學術研究機構
• 製藥公司
• 生技公司
• 受託研究機構
• 醫療和診斷相關企業

第6章 市場：宏觀經濟情景，包括利率、通貨膨脹、地緣政治、貿易戰和關稅的影響、關稅戰和貿易保護主義對供應鏈的影響，以及 COVID-19 疫情對市場的影響。

第7章：全球策略分析架構、目前市場規模、市場對比及成長率分析

• 全球腸道晶片市場：PESTEL分析
• 全球腸道晶片市場：規模、對比及成長率分析
• 全球腸道晶片市場表現：規模與成長，2020-2025年
• 全球腸道晶片市場預測：規模與成長，2025-2030年，2035年

第8章：全球市場總規模（TAM）

第9章 市場細分

• 依產品類型
• 晶片器官、晶片實驗室、微流體裝置、細胞培養平台、整合器官系統
• 透過技術
• 微流體技術、3D細胞培養技術、幹細胞技術、生物感測器整合技術
• 材料
• 聚二甲基矽氧烷、玻璃和聚合物基晶片
• 透過使用
• 藥物發現、個人化醫療、毒性測試、微生物組和腸道菌群研究、疾病建模、轉化研究
• 最終用戶
• 學術研究機構、製藥公司、生技公司、受託研究機構
• 按類型細分：器官晶片
• 晶片肝臟、晶片肺臟、晶片心臟、晶片腎臟、晶片腸髒、晶片大腦、晶片皮膚
• 按類型細分：拉蒂普實驗室
• 晶片式診斷實驗室、聚合酵素鏈鎖反應(PCR) 晶片、去氧核糖核酸(DNA) 分析晶片、蛋白質分析晶片、即時檢測 (POCT) 晶片
• 按類型細分：微流體控元件
• 微流體晶片、微型幫浦、微型閥、液滴微流體、連續流微流體
• 按類型細分：細胞培養平台
• 2D細胞培養系統、3D細胞培養系統、球狀體培養平台、支架基平台、生物反應器
• 依類型細分：綜合器官系統
• 多重器官晶片、人體晶片、身體晶片、互連組織平台、混合器官系統

第10章 區域與國別分析

第11章 亞太市場

第12章：中國市場

第13章：印度市場

第14章：日本市場

第15章：澳洲市場

第16章：印尼市場

第17章：韓國市場

第18章 台灣市場

第19章 東南亞市場

第20章 西歐市場

第21章英國市場

第22章：德國市場

第23章：法國市場

第24章：義大利市場

第25章：西班牙市場

第26章：東歐市場

第27章：俄羅斯市場

第28章 北美市場

第29章：美國市場

第30章：加拿大市場

第31章：南美市場

第32章：巴西市場

第33章 中東市場

第34章：非洲市場

第35章 市場監理與投資環境

第36章：競爭格局與公司概況

• 腸道晶片市場：競爭格局及市場佔有率（2024年）
• 腸道晶片市場：公司估值矩陣
• 腸道晶片市場：公司概況
  • Nederlandse Organisatie voor Toegepast-Natuurwetenschappelijk Onderzoek（TNO）
  • Micronit Microtechnologies BV
  • Emulate Inc.
  • CN Bio Innovations Limited
  • ibidi GmbH

第37章 其他大型企業和創新企業

• BiomimX Srl, TissUse GmbH, MIMETAS BV, Fluigent SA, AIM Biotech Pte. Ltd., 4Dcell SAS, Hesperos Inc., Bi/ond Solutions BV, SynVivo Inc., NETRI SAS, BEOnChip SL, Dynamic42 GmbH, React4Life Srl, Kirkstall Ltd., AlveoliX AG

第38章：全球市場競爭基準分析與儀錶板

第39章：預計進入市場的新創企業

第40章 重大併購

第41章 具有高市場潛力的國家、細分市場與策略

• 2030年腸道晶片市場：提供新機會的國家
• 2030年腸道晶片市場：充滿新機會的細分市場
• 2030年腸道晶片市場：成長策略
  • 基於市場趨勢的策略
  • 競爭對手的策略

第42章附錄

A gut-on-a-chip is a miniature microfluidic platform designed to reproduce the structure and biological functions of the human intestine within a compact laboratory device. It incorporates living human intestinal cells arranged inside microscopic channels that simulate the natural gut environment, including continuous fluid movement and mechanical actions such as peristalsis. This technology enables researchers to investigate digestion, nutrient absorption, interactions between the gut microbiome and intestinal tissue, as well as various intestinal diseases under physiologically relevant conditions.

The primary product types of gut-on-a-chip include organ-on-a-chip, lab-on-a-chip, microfluidic devices, cell culture platforms, and integrated organ systems. Organ-on-a-chip refers to a micro engineered platform developed to replicate the structure and physiological functions of the human gut for research and testing applications. These products utilize technologies such as microfluidics, three-dimensional cell culture, stem cell technology, and biosensor integration, and are manufactured using materials including polydimethylsiloxane, glass, and polymer-based chips. Their applications cover drug discovery, personalized medicine, toxicity testing, microbiome and gut microbiota research, disease modeling, and translational research, with end users including academic research institutions, pharmaceutical companies, biotechnology firms, and contract research organizations.

Tariffs are influencing the gut-on-a-chip market by increasing the cost of importing specialized microfluidic components, biosensors, and advanced biomaterials essential for organ-on-chip fabrication and research applications. This is significantly affecting segments such as microfluidic devices and integrated organ systems, where precision manufacturing and international supply chains play a critical role in technological advancement. Regions with strong dependence on imported laboratory equipment, particularly Asia-Pacific and Europe, are encountering slower research expansion and commercialization of organ-on-chip technologies. However, tariffs are also encouraging domestic manufacturing of microfluidic platforms, greater investment in local research and development, and the growth of regional biotechnology ecosystems to reduce dependence on global supply chains.

The gut-on-a-chip market research report is one of a series of new reports from The Business Research Company that provides gut-on-a-chip market statistics, including gut-on-a-chip industry global market size, regional shares, competitors with a gut-on-a-chip market share, detailed gut-on-a-chip market segments, market trends and opportunities, and any further data you may need to thrive in the gut-on-a-chip industry. This gut-on-a-chip market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The gut-on-a-chip market size has grown rapidly in recent years. It will grow from $0.77 billion in 2025 to $0.87 billion in 2026 at a compound annual growth rate (CAGR) of 12.7%. The growth in the historic period can be attributed to advancement in microfluidic engineering technologies, increasing research in human cell culture systems, growing demand for alternative animal testing methods, early adoption of organ-on-chip prototypes in academia, rising investment in biotechnology research infrastructure.

The gut-on-a-chip market size is expected to see rapid growth in the next few years. It will grow to $1.38 billion in 2030 at a compound annual growth rate (CAGR) of 12.3%. The growth in the forecast period can be attributed to expansion of personalized medicine and precision drug testing, increasing pharmaceutical reliance on in-vitro modeling systems, growth in microbiome research and gut health studies, development of multi-organ integrated chip platforms, rising regulatory support for alternative testing technologies. Major trends in the forecast period include microfluidic gut simulation platforms enabling real-time intestinal physiology analysis, organ-on-chip integration for personalized drug response testing, microbiome interaction modeling using advanced gut-on-chip systems, high-throughput toxicity screening using microengineered intestinal models, stem cell based intestinal tissue replication for disease modeling and regenerative research.

The increasing incidence of gastrointestinal diseases is anticipated to drive the expansion of the gut-on-a-chip market in the coming years. Gastrointestinal diseases are disorders that affect the digestive system, including the stomach, intestines, colon, and rectum, often resulting in chronic inflammation, impaired digestion, and serious intestinal complications. The growing prevalence of these diseases is largely attributed to unhealthy eating habits and the increasing intake of processed food products that adversely impact digestive health. Gut-on-a-chip technology supports gastrointestinal disease research by replicating human intestinal functions and disease conditions, enabling researchers to investigate disease mechanisms, evaluate drug responses, and develop new therapeutic approaches. For instance, in January 2024, according to the American Cancer Society, a US-based nonprofit cancer organization, colorectal cancer (CRC) is the second leading cause of cancer-related deaths in the United States, with around 53,010 projected deaths in 2024, compared to an estimated 52,550 deaths in the previous year. Therefore, the increasing incidence of gastrointestinal diseases is driving the growth of the gut-on-a-chip market.

Leading companies operating in the gut-on-a-chip market are focusing on developing advanced solutions, such as low-drug-absorbing rigid microfluidic chips, to improve predictive accuracy in absorption, distribution, metabolism, excretion, and toxicity studies. Low-drug-absorbing rigid microfluidic chips refer to advanced organ-on-chip devices manufactured using specialized plastic materials that minimize compound loss during experiments while maintaining controlled fluid flow and physiologically relevant cellular environments. For example, in September 2024, Emulate Inc., a US-based biotechnology company specializing in organ-on-a-chip platforms, human tissue models, and microfluidic research technologies, launched the Chip-R1 Rigid Chip for advanced organ-on-chip applications. The platform features low-drug-absorbing plastic construction, improved vascular channel design for physiologically relevant shear stress, and enhanced compatibility for absorption, distribution, metabolism, excretion, and toxicity testing applications in human-relevant tissue models.

In September 2023, CN Bio Innovations Ltd., a UK-based developer of organ-on-a-chip technologies, entered into a partnership with LifeNet Health LifeSciences to obtain validated primary human cells. Through this collaboration, CN Bio sought to enhance its organ-on-a-chip research capabilities by incorporating validated human cells into its PhysioMimix organ-on-a-chip platforms, improving applications in drug discovery and disease modeling. LifeNet Health LifeSciences is a US-based supplier of human tissue products, primary cells, and research biospecimens for biomedical research.

Major companies operating in the gut-on-a-chip market report are Nederlandse Organisatie voor Toegepast-Natuurwetenschappelijk Onderzoek (TNO), Micronit Microtechnologies B.V., Emulate Inc., CN Bio Innovations Limited, ibidi GmbH, BiomimX S.r.l., TissUse GmbH, MIMETAS B.V., Fluigent S.A., AIM Biotech Pte. Ltd., 4Dcell SAS, Hesperos Inc., Bi/ond Solutions B.V., SynVivo Inc., NETRI SAS, BEOnChip S.L., Dynamic42 GmbH, React4Life S.r.l., Kirkstall Ltd., AlveoliX AG, Nortis Inc., AxoSim Inc., InSphero AG, Altis Biosystems Inc., Organovo Holdings Inc.

North America was the dominating region in the gut-on-a-chip market in 2025. Asia-Pacific is expected to be the rapidly growing region in the forecast period. The regions covered in the gut-on-a-chip market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the gut-on-a-chip market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The gut-on-a-chip market consists of sales of perfusion systems, biosensors, and integrated organ-on-chip devices. values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Gut-On-A-Chip Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses gut-on-a-chip market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
• Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on end user analysis.
• Benchmark performance against key competitors based on market share, innovation, and brand strength.
• Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
• Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for gut-on-a-chip ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The gut-on-a-chip market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
• The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
• The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
• The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
• The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
• The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
• Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

• Markets Covered:1) By Product Type: Organ On A Chip; Lab On A Chip; Microfluidic Devices; Cell Culture Platforms; Integrated Organ Systems
• 2) By Technology: Microfluidics Technology; Three Dimensional Cell Culture Technology; Stem Cell Technology; Biosensor Integration Technology
• 3) By Material: Polydimethylsiloxane; Glass; Polymer Based Chips
• 4) By Application: Drug Discovery; Personalized Medicine; Toxicity Testing; Microbiome And Gut Microbiota Research; Disease Modeling; Translational Research
• 5) By End User: Academic Research; Pharmaceutical Companies; Biotechnology Firms; Contract Research Organizations
• Subsegments:
• 1) By Organ On A Chip: Liver On A Chip; Lung On A Chip; Heart On A Chip; Kidney On A Chip; Gut On A Chip; Brain On A Chip; Skin On A Chip
• 2) By Lab On A Chip: Diagnostic Lab On A Chip; Polymerase Chain Reaction Chips; Deoxyribonucleic Acid Analysis Chips; Protein Analysis Chips; Point Of Care Testing Chips
• 3) By Microfluidic Devices: Microfluidic Chips; Micro Pumps; Micro Valves; Droplet Microfluidics; Continuous Flow Microfluidics
• 4) By Cell Culture Platforms: Two Dimensional Cell Culture Systems; Three Dimensional Cell Culture Systems; Spheroid Culture Platforms; Scaffold Based Platforms; Bioreactors
• 5) By Integrated Organ Systems: Multi Organ On A Chip; Human On A Chip; Body On A Chip; Interconnected Tissue Platforms; Hybrid Organ Systems
• Companies Mentioned: Nederlandse Organisatie voor Toegepast-Natuurwetenschappelijk Onderzoek (TNO); Micronit Microtechnologies B.V.; Emulate Inc.; CN Bio Innovations Limited; ibidi GmbH; BiomimX S.r.l.; TissUse GmbH; MIMETAS B.V.; Fluigent S.A.; AIM Biotech Pte. Ltd.; 4Dcell SAS; Hesperos Inc.; Bi/ond Solutions B.V.; SynVivo Inc.; NETRI SAS; BEOnChip S.L.; Dynamic42 GmbH; React4Life S.r.l.; Kirkstall Ltd.; AlveoliX AG; Nortis Inc.; AxoSim Inc.; InSphero AG; Altis Biosystems Inc.; Organovo Holdings Inc.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time Series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: Word, PDF or Interactive Report
• + Excel Dashboard
• Added Benefits
• Bi-Annual Data Update
• Customisation
• Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Table of Contents

1. Executive Summary

• 1.1. Key Market Insights (2020-2035)
• 1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots
• 1.3. Major Factors Driving the Market
• 1.4. Top Three Trends Shaping the Market

2. Gut-On-A-Chip Market Characteristics

• 2.1. Market Definition & Scope
• 2.2. Market Segmentations
• 2.3. Overview of Key Products and Services
• 2.4. Global Gut-On-A-Chip Market Attractiveness Scoring And Analysis
  • 2.4.1. Overview of Market Attractiveness Framework
  • 2.4.2. Quantitative Scoring Methodology
  • 2.4.3. Factor-Wise Evaluation
• Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation
• 2.4.4. Market Attractiveness Scoring and Interpretation
• 2.4.5. Strategic Implications and Recommendations

3. Gut-On-A-Chip Market Supply Chain Analysis

• 3.1. Overview of the Supply Chain and Ecosystem
• 3.2. List Of Key Raw Materials, Resources & Suppliers
• 3.3. List Of Major Distributors and Channel Partners
• 3.4. List Of Major End Users

4. Global Gut-On-A-Chip Market Trends And Strategies

• 4.1. Key Technologies & Future Trends
  • 4.1.1 Biotechnology, Genomics & Precision Medicine
  • 4.1.2 Artificial Intelligence & Autonomous Intelligence
  • 4.1.3 Internet of Things (IoT), Smart Infrastructure & Connected Ecosystems
  • 4.1.4 Digitalization, Cloud, Big Data & Cybersecurity
  • 4.1.5 Industry 4.0 & Intelligent Manufacturing
• 4.2. Major Trends
  • 4.2.1 Microfluidic Gut Simulation Platforms Enabling Real-Time Intestinal Physiology Analysis
  • 4.2.2 Organ-On-Chip Integration For Personalized Drug Response Testing
  • 4.2.3 Microbiome Interaction Modeling Using Advanced Gut-On-Chip Systems
  • 4.2.4 High-Throughput Toxicity Screening Using Microengineered Intestinal Models
  • 4.2.5 Stem Cell Based Intestinal Tissue Replication For Disease Modeling And Regenerative Research

5. Gut-On-A-Chip Market Analysis Of End Use Industries

• 5.1 Academic Research Institutions
• 5.2 Pharmaceutical Companies
• 5.3 Biotechnology Firms
• 5.4 Contract Research Organizations
• 5.5 Healthcare And Diagnostic Companies

6. Gut-On-A-Chip Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Gut-On-A-Chip Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

• 7.1. Global Gut-On-A-Chip PESTEL Analysis (Political, Economical, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 7.2. Global Gut-On-A-Chip Market Size, Comparisons And Growth Rate Analysis
• 7.3. Global Gut-On-A-Chip Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
• 7.4. Global Gut-On-A-Chip Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Gut-On-A-Chip Total Addressable Market (TAM) Analysis for the Market

• 8.1. Definition and Scope of Total Addressable Market (TAM)
• 8.2. Methodology and Assumptions
• 8.3. Global Total Addressable Market (TAM) Estimation
• 8.4. TAM vs. Current Market Size Analysis
• 8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Gut-On-A-Chip Market Segmentation

• 9.1. Global Gut-On-A-Chip Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Organ On A Chip, Lab On A Chip, Microfluidic Devices, Cell Culture Platforms, Integrated Organ Systems
• 9.2. Global Gut-On-A-Chip Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Microfluidics Technology, Three Dimensional Cell Culture Technology, Stem Cell Technology, Biosensor Integration Technology
• 9.3. Global Gut-On-A-Chip Market, Segmentation By Material, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Polydimethylsiloxane, Glass, Polymer Based Chips
• 9.4. Global Gut-On-A-Chip Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Drug Discovery, Personalized Medicine, Toxicity Testing, Microbiome And Gut Microbiota Research, Disease Modeling, Translational Research
• 9.5. Global Gut-On-A-Chip Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Academic Research, Pharmaceutical Companies, Biotechnology Firms, Contract Research Organizations
• 9.6. Global Gut-On-A-Chip Market, Sub-Segmentation Of Organ On A Chip, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Liver On A Chip, Lung On A Chip, Heart On A Chip, Kidney On A Chip, Gut On A Chip, Brain On A Chip, Skin On A Chip
• 9.7. Global Gut-On-A-Chip Market, Sub-Segmentation Of Lab On A Chip, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Diagnostic Lab On A Chip, Polymerase Chain Reaction Chips, Deoxyribonucleic Acid Analysis Chips, Protein Analysis Chips, Point Of Care Testing Chips
• 9.8. Global Gut-On-A-Chip Market, Sub-Segmentation Of Microfluidic Devices, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Microfluidic Chips, Micro Pumps, Micro Valves, Droplet Microfluidics, Continuous Flow Microfluidics
• 9.9. Global Gut-On-A-Chip Market, Sub-Segmentation Of Cell Culture Platforms, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Two Dimensional Cell Culture Systems, Three Dimensional Cell Culture Systems, Spheroid Culture Platforms, Scaffold Based Platforms, Bioreactors
• 9.10. Global Gut-On-A-Chip Market, Sub-Segmentation Of Integrated Organ Systems, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Multi Organ On A Chip, Human On A Chip, Body On A Chip, Interconnected Tissue Platforms, Hybrid Organ Systems

10. Gut-On-A-Chip Market Regional And Country Analysis

• 10.1. Global Gut-On-A-Chip Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• 10.2. Global Gut-On-A-Chip Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Gut-On-A-Chip Market

• 11.1. Asia-Pacific Gut-On-A-Chip Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 11.2. Asia-Pacific Gut-On-A-Chip Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Material, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Gut-On-A-Chip Market

• 12.1. China Gut-On-A-Chip Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 12.2. China Gut-On-A-Chip Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Material, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Gut-On-A-Chip Market

• 13.1. India Gut-On-A-Chip Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Material, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Gut-On-A-Chip Market

• 14.1. Japan Gut-On-A-Chip Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 14.2. Japan Gut-On-A-Chip Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Material, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Gut-On-A-Chip Market

• 15.1. Australia Gut-On-A-Chip Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Material, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Gut-On-A-Chip Market

• 16.1. Indonesia Gut-On-A-Chip Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Material, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Gut-On-A-Chip Market

• 17.1. South Korea Gut-On-A-Chip Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 17.2. South Korea Gut-On-A-Chip Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Material, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Gut-On-A-Chip Market

• 18.1. Taiwan Gut-On-A-Chip Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 18.2. Taiwan Gut-On-A-Chip Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Material, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Gut-On-A-Chip Market

• 19.1. South East Asia Gut-On-A-Chip Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 19.2. South East Asia Gut-On-A-Chip Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Material, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Gut-On-A-Chip Market

• 20.1. Western Europe Gut-On-A-Chip Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 20.2. Western Europe Gut-On-A-Chip Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Material, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Gut-On-A-Chip Market

• 21.1. UK Gut-On-A-Chip Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Material, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Gut-On-A-Chip Market

• 22.1. Germany Gut-On-A-Chip Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Material, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Gut-On-A-Chip Market

• 23.1. France Gut-On-A-Chip Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Material, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Gut-On-A-Chip Market

• 24.1. Italy Gut-On-A-Chip Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Material, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Gut-On-A-Chip Market

• 25.1. Spain Gut-On-A-Chip Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Material, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Gut-On-A-Chip Market

• 26.1. Eastern Europe Gut-On-A-Chip Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 26.2. Eastern Europe Gut-On-A-Chip Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Material, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Gut-On-A-Chip Market

• 27.1. Russia Gut-On-A-Chip Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Material, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Gut-On-A-Chip Market

• 28.1. North America Gut-On-A-Chip Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 28.2. North America Gut-On-A-Chip Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Material, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Gut-On-A-Chip Market

• 29.1. USA Gut-On-A-Chip Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 29.2. USA Gut-On-A-Chip Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Material, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Gut-On-A-Chip Market

• 30.1. Canada Gut-On-A-Chip Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 30.2. Canada Gut-On-A-Chip Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Material, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Gut-On-A-Chip Market

• 31.1. South America Gut-On-A-Chip Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 31.2. South America Gut-On-A-Chip Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Material, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Gut-On-A-Chip Market

• 32.1. Brazil Gut-On-A-Chip Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Material, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Gut-On-A-Chip Market

• 33.1. Middle East Gut-On-A-Chip Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 33.2. Middle East Gut-On-A-Chip Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Material, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Gut-On-A-Chip Market

• 34.1. Africa Gut-On-A-Chip Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 34.2. Africa Gut-On-A-Chip Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Material, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Gut-On-A-Chip Market Regulatory and Investment Landscape

36. Gut-On-A-Chip Market Competitive Landscape And Company Profiles

• 36.1. Gut-On-A-Chip Market Competitive Landscape And Market Share 2024
  • 36.1.1. Top 10 Companies (Ranked by revenue/share)
• 36.2. Gut-On-A-Chip Market - Company Scoring Matrix
  • 36.2.1. Market Revenues
  • 36.2.2. Product Innovation Score
  • 36.2.3. Brand Recognition
• 36.3. Gut-On-A-Chip Market Company Profiles
  • 36.3.1. Nederlandse Organisatie voor Toegepast-Natuurwetenschappelijk Onderzoek (TNO) Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.2. Micronit Microtechnologies B.V. Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.3. Emulate Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.4. CN Bio Innovations Limited Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.5. ibidi GmbH Overview, Products and Services, Strategy and Financial Analysis

37. Gut-On-A-Chip Market Other Major And Innovative Companies

• BiomimX S.r.l., TissUse GmbH, MIMETAS B.V., Fluigent S.A., AIM Biotech Pte. Ltd., 4Dcell SAS, Hesperos Inc., Bi/ond Solutions B.V., SynVivo Inc., NETRI SAS, BEOnChip S.L., Dynamic42 GmbH, React4Life S.r.l., Kirkstall Ltd., AlveoliX AG

38. Global Gut-On-A-Chip Market Competitive Benchmarking And Dashboard

39. Upcoming Startups in the Market

40. Key Mergers And Acquisitions In The Gut-On-A-Chip Market

41. Gut-On-A-Chip Market High Potential Countries, Segments and Strategies

• 41.1 Gut-On-A-Chip Market In 2030 - Countries Offering Most New Opportunities
• 41.2 Gut-On-A-Chip Market In 2030 - Segments Offering Most New Opportunities
• 41.3 Gut-On-A-Chip Market In 2030 - Growth Strategies
  • 41.3.1 Market Trend Based Strategies
  • 41.3.2 Competitor Strategies

42. Appendix

• 42.1. Abbreviations
• 42.2. Currencies
• 42.3. Historic And Forecast Inflation Rates
• 42.4. Research Inquiries
• 42.5. The Business Research Company
• 42.6. Copyright And Disclaimer